Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study.

Djoussé L, Bartz TM, Ix JH, Kochar J, Kizer JR, Gottdiener JS, Tracy RP, Mozaffarian D, Siscovick DS, Mukamal KJ, Zieman SJ.

Eur J Heart Fail. 2013 Apr;15(4):394-9. doi: 10.1093/eurjhf/hfs196. Epub 2012 Dec 6.

2.

Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study).

Miedema MD, Maziarz M, Biggs ML, Zieman SJ, Kizer JR, Ix JH, Mozaffarian D, Tracy RP, Psaty BM, Siscovick DS, Mukamal KJ, Djousse L.

Am J Cardiol. 2014 Sep 15;114(6):843-8. doi: 10.1016/j.amjcard.2014.06.012. Epub 2014 Jul 1.

3.

Plasma fatty acid-binding protein 4, nonesterified fatty acids, and incident diabetes in older adults.

Djoussé L, Khawaja O, Bartz TM, Biggs ML, Ix JH, Zieman SJ, Kizer JR, Tracy RP, Siscovick DS, Mukamal KJ.

Diabetes Care. 2012 Aug;35(8):1701-7. doi: 10.2337/dc11-1690. Epub 2012 May 14.

4.

Cystatin C concentration as a risk factor for heart failure in older adults.

Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study.

Ann Intern Med. 2005 Apr 5;142(7):497-505.

PMID:
15809461
5.

Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.

de Simone G, Devereux RB, Roman MJ, Chinali M, Barac A, Panza JA, Lee ET, Galloway JM, Howard BV.

Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):285-91. doi: 10.1016/j.numecd.2011.06.007. Epub 2011 Sep 21.

6.

Height and risk of heart failure in the Physicians' Health Study.

Akinkuolie AO, Aleardi M, Ashaye AO, Gaziano JM, Djoussé L.

Am J Cardiol. 2012 Apr 1;109(7):994-7. doi: 10.1016/j.amjcard.2011.11.032. Epub 2012 Jan 3.

7.

Risk factors for heart failure in the elderly: a prospective community-based study.

Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM.

Am J Med. 1999 Jun;106(6):605-12.

PMID:
10378616
8.

Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study.

Djoussé L, Benkeser D, Arnold A, Kizer JR, Zieman SJ, Lemaitre RN, Tracy RP, Gottdiener JS, Mozaffarian D, Siscovick DS, Mukamal KJ, Ix JH.

Circ Heart Fail. 2013 Sep 1;6(5):964-9. doi: 10.1161/CIRCHEARTFAILURE.113.000521. Epub 2013 Aug 7.

9.

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Dubin R, Li Y, Ix JH, Shlipak MG, Whooley M, Peralta CA.

Am Heart J. 2012 Feb;163(2):274-9. doi: 10.1016/j.ahj.2011.11.007.

10.

Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.

Rea TD, Psaty BM, Heckbert SR, Cushman M, Meilahn E, Olson JL, Lemaitre RN, Smith NL, Sotoodehnia N, Chaves PH.

J Womens Health (Larchmt). 2003 May;12(4):341-50.

PMID:
12804341
11.

The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.

Barzilay JI, Kronmal RA, Gottdiener JS, Smith NL, Burke GL, Tracy R, Savage PJ, Carlson M.

J Am Coll Cardiol. 2004 Jun 16;43(12):2236-41.

12.

Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J.

J Am Soc Nephrol. 2007 Apr;18(4):1307-15. Epub 2007 Mar 7.

13.

C-reactive protein and risk of heart failure. The Rotterdam Study.

Kardys I, Knetsch AM, Bleumink GS, Deckers JW, Hofman A, Stricker BH, Witteman JC.

Am Heart J. 2006 Sep;152(3):514-20.

PMID:
16923423
14.
15.

Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.

Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K.

Am J Kidney Dis. 2009 Jan;53(1):59-69. doi: 10.1053/j.ajkd.2008.07.027. Epub 2008 Oct 5. Erratum in: Am J Kidney Dis. 2009 May;53(5):913.

PMID:
18838200
16.

Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study.

Khan H, Kunutsor S, Rauramaa R, Savonen K, Kalogeropoulos AP, Georgiopoulou VV, Butler J, Laukkanen JA.

Eur J Heart Fail. 2014 Feb;16(2):180-8. doi: 10.1111/ejhf.37. Epub 2013 Dec 14.

17.

Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study.

Nanchen D, Stott DJ, Gussekloo J, Mooijaart SP, Westendorp RG, Jukema JW, Macfarlane PW, Cornuz J, Rodondi N, Buckley BM, Ford I, Sattar N, de Craen AJ; PROSPER Group.

Eur J Heart Fail. 2013 May;15(5):581-8. doi: 10.1093/eurjhf/hfs195. Epub 2012 Dec 18.

18.

Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study).

Karas MG, Benkeser D, Arnold AM, Bartz TM, Djousse L, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, Mantzoros CS, Gottdiener JS, deFilippi CR, Kizer JR.

Am J Cardiol. 2014 Jan 15;113(2):328-34. doi: 10.1016/j.amjcard.2013.09.027. Epub 2013 Oct 3.

19.

Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Am J Cardiol. 2007 Nov 15;100(10):1571-6.

PMID:
17996522
20.

Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study.

van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, Stricker BH, Witteman JC.

Eur Heart J. 2006 Oct;27(19):2346-52. Epub 2006 Sep 4.

PMID:
16952920

Supplemental Content

Support Center